Feb 4, 2026 06:27AM Compass Therapeutics (CMPX) PT Raised to $13 at Canaccord Genuity

Jan 7, 2026 04:10AM Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens

Jan 6, 2026 01:40PM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Jan 6, 2026 10:11AM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX)

Jan 6, 2026 08:01AM Compass Therapeutics reports $209 million cash, appoints new executives

Jan 5, 2026 08:01AM Compass Therapeutics names new commercial and medical officers

Jan 5, 2026 04:31AM William Blair Starts Compass Therapeutics (CMPX) at Outperform

Dec 30, 2025 04:05PM Compass Therapeutics, Inc (CMPX) files $400M mixed shelf

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 3, 2025 06:07AM Cantor Fitzgerald Starts Compass Therapeutics (CMPX) at Overweight

Dec 3, 2025 05:15AM Canaccord Genuity Starts Compass Therapeutics (CMPX) at Buy

Dec 3, 2025 03:16AM Citizens Starts Compass Therapeutics (CMPX) at Market Outperform

Nov 4, 2025 09:01AM Compass Therapeutics presents preclinical data for cancer bispecific antibody

Aug 18, 2025 06:34AM Piper Sandler on Compass Therapeutics (CMPX): 'Early '8371 Responses Are Super Interesting'

Aug 12, 2025 07:04AM Compass Therapeutics (CMPX) PT Raised to $12 at Guggenheim

Aug 11, 2025 04:27PM Compass Therapeutics (CMPX) PT Raised to $7 at Leerink Partners

Aug 11, 2025 01:58PM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX)

Aug 11, 2025 07:46AM Compass Therapeutics, Inc. (CMPX) Misses Q2 EPS by 2c

Jul 14, 2025 09:59AM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Jul 1, 2025 06:24AM Raymond James Resumes Compass Therapeutics (CMPX) at Outperform

May 8, 2025 05:29PM Compass Therapeutics, Inc. (CMPX) Misses Q1 EPS by 1c

Apr 29, 2025 07:28AM H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)

Apr 22, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)

Apr 21, 2025 08:00AM Compass Therapeutics (CMPX) Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer

Apr 2, 2025 06:49AM Leerink Partners Upgrades Compass Therapeutics (CMPX) to Outperform

Apr 1, 2025 07:01AM Compass Therapeutics, Inc (CMPX) Reports CTX-009 Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study

Mar 31, 2025 04:07PM Compass Therapeutics (CMPX) to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer

Mar 10, 2025 04:31PM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Feb 28, 2025 04:39AM Compass Therapeutics, Inc. (CMPX) Misses Q4 EPS by 1c

Feb 19, 2025 04:05AM Piper Sandler Starts Compass Therapeutics (CMPX) at Overweight

Jan 8, 2025 08:04AM Compass Therapeutics (CMPX) Provides Corporate Update and Announces Advancement of a New Drug Candidate

Dec 10, 2024 08:12AM Compass Therapeutics (CMPX) Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

Nov 12, 2024 08:01AM Compass Therapeutics, Inc. (CMPX) Tops Q3 EPS by 3c

Sep 16, 2024 06:49AM Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) to Buy

Aug 12, 2024 08:01AM Compass Therapeutics, Inc. (CMPX) Reports In-Line Q2 EPS